Grantees of the André and Michel Bouriez Foundation
2022
Dr Noémie Sachs-Guedj
Surgeon in Gynecology-Obstetrics – University Hospitals of Geneva (Switzerland)
Study on the optimization of the luteal phase in assisted reproduction medicine ; determination of the dose of progesterone, its mode and duration of administration in order to optimize the success rate of assisted procreation by implantation of frozen embryos.
Dexeus University Hospital (Barcelone – Spain) ; Reproductive Medicine Service – Pr. Nikolaos Polyzos ; from July 1st 2022 to June 30th 2024
Grant: 59.300 CHF
Since her return to Geneva, Dr. Sachs-Guedj has been appointed Chief Resident at HUG.
2023
Dr Isabel Fernandes Arroteia
Surgeon in Neurology – Centre Hôspitalier du Luxembourg (Luxembourg)
Validation of the use of point of care tumor methylome analysis using new generation nanopore sequencing (NanoDIP/EpiDIP), coupled to ultra-fast non supervised machine learning algorithms in the diagnosis of pediatric brain tumors and evaluate its impact on perioperative decision making, further treatment and the prognosis of the patient;
University Hospital Basel (Switzerland); Department of Paediatric Neurosurgery– Prof. Raphael Guzman ; from Oct. 16th, 2023 to Oct. 16th, 2024.
Grant : 50.000 CHF
2023
Dr Urs Fisch
Neurologist – Hôpital Universitaire of Basel (Switzerland)
Study on the factors and medical signals that allow determining the probabilities of remission in patients who, after a cardiac arrest, are in a coma and exhibit epileptic activity. The conclusions will help refine the vital diagnosis of patients and enable intensive care units to make better decisions regarding treatment options.
Brigham and Women’s Hospital, Harvard University (Boston, USA) ; Neurology Department – Pr. Jong Jee ; from Jan. 1st 2024 to June 30th 2025.
Grant : 50.000 CHF.
2024
Dr Belkacem Acidi
Hepatobiliary Surgeon – Hôpital Paul-Brousse Ap-Hp Paris (France)
Study aiming to develop and validate (in vivo and ex vivo) intraoperative navigation tools in hepatobiliary surgery. The project focuses on integrating artificial intelligence (AI) into intraoperative ultrasound, using the MasSpecPen to refine tissue characterization The project includes the development of three-dimensional (3D) models to optimize the planning and execution of surgical procedures.
MD Anderson Cancer Center – University of Texas (Houston, USA) ; Oncological Surgery Service – Pr. Tran Cao ; from January 1st 2024 to October 31st 2024.
Grant : 40.000 CHF.
2024
Dr Amir El Rahal
Neurosurgeon – University Hospitals of Geneva (HUG) (Switzerland)
Study aimed at optimizing the detection of the cellular phenotype of central nervous system tumors through morphometric extraction, incorporating new neural network tools, and utilizing new technologies such as Stimulated Raman Histology (SRH) associated with a new technical tool developed in Freiburg based on AI and big data.
Medical Center University of Freiburg im Breisgau, (Freiburg im Breisgau, Germany); Department of Neurosurgery, Microenvironment and Tumor Immunology Laboratory (MiLoLab) – Prof. Jürgen Beck; From January 1, 2024, to June 30, 2025.
Grant : 40.000 CHF.
2025
Dr Filippo Nicoletti
Neurologue – HôpNeurologist – University Hospital Essen (Germany) and University Hospital Zurich (Switzerland)
Study aimed at reconstructing vascular network segments of patients with cerebral amyloid angiopathy (CAA) using three-dimensional imaging (using IMARIS software) to gain a better understanding of the spatial and temporal mechanisms of this pathology and determine its causes. The objective is to identify markers and define factors that enable a medical prognosis.
Institut du Cerveau (Paris, France) – Prof. Danielle Seilhean; From January 1, 2025 to December 31, 2026.
Grant : 85.300 CHF.
2025
Dr Dario Saracino
Neurologist – Hôpital Universitaire de la Pitié-Salpêtrière (Paris)
Study aimed at revealing indirect signs of intraneuronal accumulation of TDP-43, the most common pathological substrate for frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS); to characterize the role of TDP-43 inclusions in disease progression and severity; to validate easily accessible and reproducible tests to identify and monitor the proteinopathy TDP-43 throughout the course of the disease.
International Center for Genetic Engineering and Biotechnology (Trieste – Italy) – Prof. Emanuele Buratti; from September 1, 2025 to August 31, 2026.
Grant : 42.650 CHF.
2025
Dr Martin Dubois
Haematologist – Jules Bordet Institute – Brussels University Hospital (Belgium).
Study aimed at analysing the effects of ferroptosis on the antiporter xCT in order to inhibit the latter and induce leukemic cell death, thus fighting against acute myeloid leukemia (AML); discover and test new ferroptosis-inducing molecules derived from sulfasalazine.
Saint-Louis Research Institute INSERM (Paris, France) – Prof. Raphael Itzykson; from November 1, 2025 to October 31, 2026.
Grant : 42.650 CHF.
2025
Dr Dimitrios Kalaitzopoulos
Gynaecologist – Schaffhausen Cantonal Hospital (Switzerland).
Study aimed at defining the microbiological causes of chronic endometritis, to characterize the role of the microorganisms (microbiome) that are present in the endometrium in the chronic endometritis; to characterize the utility of such microbiological analysis for the diagnosis.
Brussels IVF, University Hospital of the Université Libre de Bruxelles (Belgium) – Prof. Herman Tournaye; from January 1, 2026 to December 31, 2026.
Grant : 50.000 CHF.
